While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

The US FDA has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Patients with bronchiectasis in China have a high disease burden and a low rate of use of evidence-based treatments.

For children with OSA with NE, the remission rate of NE is more than half for those undergoing adenoidectomy and/or tonsillectomy.

For children with atopic dermatitis, early childhood stressful life events are associated with an increased risk for disease activity.

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

Exposure to traffic-related air pollution is associated with depression in women, possibly via reproductive health.

In adults with cystic fibrosis, gastrointestinal symptoms initially improve with ETI but most do not consistently improve with longer-term use.

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread.

The median length of survival for individuals with ILD who completed pulmonary rehabilitation was 6.1 years vs 4.7 years in the control group. Pulmonary rehabilitation (PR) may improve survival at 5 ...